Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heyi Chen

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Medicine Reports|November 18, 2021
CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathwayLinjin Li, Yiren Hu, Dake Chen, et al.
Journal of Cancer|June 24, 2024
Establishment of a SUMO pathway related gene signature for predicting prognosis, chemotherapy response and investigating the role of EGR2 in bladder cancerHan Xiao, Xiaoan Huang, Heyi Chen, et al.
Frontiers in Immunology|May 1, 2025
The role of the LncRNA XIST/miR-15a-5p/MN1 signaling axis in gender disparities in bladder cancer prognosisFangzhen Cai, Siwei Xu, Yinan Li, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Medicine Reports|November 18, 2021
CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathwayLinjin Li, Yiren Hu, Dake Chen, et al.
Journal of Cancer|June 24, 2024
Establishment of a SUMO pathway related gene signature for predicting prognosis, chemotherapy response and investigating the role of EGR2 in bladder cancerHan Xiao, Xiaoan Huang, Heyi Chen, et al.
Frontiers in Immunology|May 1, 2025
The role of the LncRNA XIST/miR-15a-5p/MN1 signaling axis in gender disparities in bladder cancer prognosisFangzhen Cai, Siwei Xu, Yinan Li, et al.
Pageof 2